This document summarizes Nigeria's experience implementing the GxAlert connectivity tool for GeneXpert machines. Key points include:
- GxAlert allows GeneXpert machines to report test results in real-time via a secure online network, making results actionable within the health system.
- Over 200 GeneXpert machines in Nigeria are now connected via GxAlert. This enables real-time notification of test results, machine errors, and stock levels.
- Challenges include inconsistent internet availability, incomplete primary data, and a need to better integrate GxAlert with other electronic reporting systems like e-TB Manager and DHIS2. Support is also needed to sustain connectivity and uniquely identify patients.
GxAlert Monitors and Reduces High Testing Error Rates in Nigeria's GeneXpert ...SystemOne
Presentation on the use of SystemOne's GxAlert tool in Nigeria, for monitoring reducing diagnostic errors and accelerating positive outcomes in TB.
Published courtesy of Kehinde Jimoh Agbaiyero, Senior Technical Advisor - TB, Abt Associates
GxAlert Monitors and Reduces High Testing Error Rates in Nigeria's GeneXpert ...SystemOne
Presentation on the use of SystemOne's GxAlert tool in Nigeria, for monitoring reducing diagnostic errors and accelerating positive outcomes in TB.
Published courtesy of Kehinde Jimoh Agbaiyero, Senior Technical Advisor - TB, Abt Associates
Ipsos Healthcare executed a study on the future of connected health in the areas of patient-generated health data, security and the role of connected health in care outcomes.
During this webinar we will discuss getting the maximum MU measure from your CPOE and e-prescribing as well as making sure you are hitting all the key buttons to get the most out of your medication prescribing for Meaningful Use.
Community pharmacy anticoagulation monitoring service, the Canterbury approach. Presented by Vanessa Buchan, Canterbury Health Laboratories, at HINZ 2014, 11 November 2014, 12pm, Marlborough Room
AMCCBS Virtual2021 Conference Takeaways Part 1Carevive
Takeaways from Carevive's March 2nd presentation featuring Ethan Basch, Madelyn Trupkin Herzfeld, Bruno Lempernesse, and Nadia Still DNP, RN.
Learn more about Carevive's breakthrough cancer care platform:
https://bit.ly/3bJ5H1z
Tracey Grainger, Head of Digital Primary Care Development, NHS England
Dr Robert Varnham,GP and Head of General Practice, NHS England
Tracey Watson, Head of Partners & Commercial Strategic Systems & Technology, Patients & Information, NHS England
The Benefits of a Seamless IRT and EDC Integration in Clinical Trial ExecutionVeeva Systems
Watch the video here: https://bit.ly/3upehbN
Veeva and Suvoda have combined their offerings into a powerful streamlined integration, which accommodates advanced study designs while driving down build and casebook complexity.
Hear Catherine Munera, head of biometrics at Cara Therapeutics, share the benefits of moving from a single provider to taking a harmonized, best-of-breed approach with IRT and EDC.
Ipsos Healthcare executed a study on the future of connected health in the areas of patient-generated health data, security and the role of connected health in care outcomes.
During this webinar we will discuss getting the maximum MU measure from your CPOE and e-prescribing as well as making sure you are hitting all the key buttons to get the most out of your medication prescribing for Meaningful Use.
Community pharmacy anticoagulation monitoring service, the Canterbury approach. Presented by Vanessa Buchan, Canterbury Health Laboratories, at HINZ 2014, 11 November 2014, 12pm, Marlborough Room
AMCCBS Virtual2021 Conference Takeaways Part 1Carevive
Takeaways from Carevive's March 2nd presentation featuring Ethan Basch, Madelyn Trupkin Herzfeld, Bruno Lempernesse, and Nadia Still DNP, RN.
Learn more about Carevive's breakthrough cancer care platform:
https://bit.ly/3bJ5H1z
Tracey Grainger, Head of Digital Primary Care Development, NHS England
Dr Robert Varnham,GP and Head of General Practice, NHS England
Tracey Watson, Head of Partners & Commercial Strategic Systems & Technology, Patients & Information, NHS England
The Benefits of a Seamless IRT and EDC Integration in Clinical Trial ExecutionVeeva Systems
Watch the video here: https://bit.ly/3upehbN
Veeva and Suvoda have combined their offerings into a powerful streamlined integration, which accommodates advanced study designs while driving down build and casebook complexity.
Hear Catherine Munera, head of biometrics at Cara Therapeutics, share the benefits of moving from a single provider to taking a harmonized, best-of-breed approach with IRT and EDC.
Impact of health education on tuberculosis drug adherenceSkillet Tony
Adherence is defined as the extent to which patients follow the instructions they are given for prescribed treatments. Until recently, adherence expertise was hard to find, assemble and empower. The study shall solely aim at investigating the influence of patients’ health education on Tuberculosis drug adherence. It will be guided by the following specific objectives; to identify the level of adherence among TB patients at MTRH, to assess the level of patient’s health education on TB drugs, to identify barriers of TB education, to investigate the challenges facing TB patients on treatment and to determine the level of training given to health workers on TB drug adherence. These objectives will enable the researcher to elaborate more on the topic and ensure that those who read through this research shall have a better perspective on the effects of health education on tuberculosis drug adherence. It will take place between the months of July and August. The study will target 17 doctors, 119 nurses and 143 patients of Tuberculosis. The study will employ a case study research design. The case study will enable the researcher be able to collected detailed information as to the influence of patients’ health education on TB drug adherence. The study will employ purposive sampling to sample the doctors and simple random sampling to select both the nurses and the patients who will participate in the study. The researcher will use one research instrument to collect data from the respondents selected to participate in the study which is a questionnaire that will be issued to the respondents on the day of the data collection.
Tuberculosis Infection Control Symposia, presented at Hôpital Sacré Coeur in Milot, Haiti, 2011.
CRUDEM’s Education Committee (a subcommittee of the Board of Directors) sponsors one-week medical symposia on specific medical topics, i.e. diabetes, infectious disease. The classes are held at Hôpital Sacré Coeur and doctors and nurses come from all over Haiti to attend.
Opportunities & Challenges in West Africa's (Ghana & Nigeria) Healthcare and ...Aiswariya Chidambaram
This presentation made at the Pharma Insights Briefing session of CPhI Worldwide 2014, Paris, provides information on the market opportunities of
the fastest growing pharmaceutical markets in Africa: Ghana and Nigeria.
• Market sizing and Growth Trends
• Key Merger, Acquisition and Partnership Assessment
• Market Drivers and Challenges
• Pharmaceutical Procurement, Supply, Distribution and Retail
• SWOT and PESTLE Analysis
• Competitive Landscape Analysis
• Therapeutic Area Growth Analysis
• Strategic Recommendations
Heavily based on a presentation I gave for the CMS 2020 National Quality Forum. Emphasis is on dialysis (particularly home dialysis). Discusses regulatory framework, medical devices used to render the services and outcomes of studies performed to day
Teleradiology Benefits :
Improved Communication
Immediate accessibility to ER doctor/specialist
Support for Technologist – protocols, rescans
Radiologist Productivity, Efficiency, Lifestyle
Cost benefit – economy of scale
I did a visit to new zealand in 2003 and did a number of talks from 2003 to 2005 on the transformation taking place in new zealand. back in NZ in 2014 so looked at those early slide so impressed with the leadership and the robust primary care
From the Archives, 2008:Clinical and Economic Advantages Implantable Defibril...David Lee Scher, MD
This presentation from 2008 discusses the most early recognized merits of remote patient monitoring as it pertained to implantable defibrillators. It was prsented at the European Cardiac Arrhythmia Society Annual Congress. These advantages of RPM can be extended to monitoring of other conditions today.
Real world clinical medical data. Corporate presentation of Ad Scientiam which is a startup specialized in real life data acquisition during clinical trials.
Learn more at : www.adscientiam.com
Feasibility of an SMS intervention to deliver tuberculosis testing results in...SystemOne
Pre-treatment loss to follow-up is common for patients diagnosed with tuberculosis (TB) in high-burden countries. Delivering test results by SMS is increasingly being considered as a solution, but there is limited information about its feasibility as a public health tool in low resourced settings. It was found that reporting Xpert results via automated SMS is technically feasible and results in approximately half of patients receiving their test results immediately. Additional research should be done to address process inefficiencies in order to maximize impact of this technology and link its successful utilization to improved patient outcomes.
The Role of Connected Diagnostics in Strengthening Regional, National and Con...SystemOne
Although numerous disease intelligence and surveillance systems exist, they are plagued with inaccurate or untimely data. We contend, furthermore, that it was this lack of data quality – and not
the lack of surveillance systems or networks – that prevented the global community from acting earlier in response to the Ebola outbreak in 2014–2016. The new field of ‘connected diagnostics’ is one solution to this concern, as it automates data collection directly from the diagnostic instruments to multiple levels of stakeholders for real-time decision-making and policy response.
This article details how the intervention of ‘connected diagnostics’ could solve the primary underlying failure in existing surveillance systems – the lack of accurate and timely data – to enable
difficult political decisions earlier. The use of connectivity solutions can enable critical health and operational data to empower the Africa CDC, regional hubs, and each country with a consistent
and automated data feed while still maintaining country privacy and controls.
GxAlert for Real-time Management and Strengthening of Remote GeneXpert Networ...SystemOne
Real-time monitoring of GeneXpert machines can contribute to reduced error rates and shorter turnaround
times for module replacement and can improve the overall
maintenance of the machines. Emails and SMS alerts can speed
up treatment initiation. The NTP now gets SMS alerts and emails for DR-TB patient enrollment; stockout and error (>5%) rates; critical module errors; and monthly MDR reports to ensure better
connections among diagnosis, enrollment, and treatment.
Racing for results: lessons learnt in improving the efficiency of HIV VL and ...SystemOne
In pursuit of the 90–90–90 goals, emphasis has been placed on accelerating centralized laboratory HIV viral load testing of a population that is largely rural and decentralized. Successful
outcome requires effective specimen transport, laboratory testing, and results delivery. This paper focuses on the methods currently employed for results delivery. New innovations in this area are
yielding mixed results; we analyze different approaches and estimate the impact of each on achieving the third ‘90.’
GxAlert Papua New Guinea Case Study 072518SystemOne
GxAlert's use in Papua New Guinea for disease surveillance and response. Initially used for Tuberculosis response, device management and second-line drug forecasting and stockage.
Bangladesh case study on how we implemented a connected diagnostics solution using GxAlert for infectious disease surveillance, TB program optimization and leveraging diagnostic data.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
On the ground experiences & challenges of a connected diagnostics GxAlert in Nigeria
1. On the ground experiences and challenges of a
connected diagnostics-GX Alert in Nigeria
47th Union World Conference on Lung Health
Liverpool, England
Oct 26 - 29, 2016
Gidado M., Peter, N., Elom, E., Gabriel A.,
Rupert E., Useni S., Nkem C., Kuye J.
2. Acknowledgement & declaration of
conflict of interest
All colleagues in NTP; Abts associates and system
one; USAID.
I have no conflict of interest and I take
responsibilities for the content of the presentation
4. Summary
GxAlert connectivity is a laboratory
management tool if implemented
effectively.
However
“matching the right technology with
the right problem can be challenging”
(Lombardo, & Buckeridge, 2007)
5. Introduction--1
4th in-terms of Global TB burden
Highest TB burden in Africa.
TB incidence: 322/100,000 population
TB treatment coverage-CDR is 15%,
National HIV prevalence- 3.4%
TB/HIV co-infection 17%
Prevalence of MDR-TB among New
Cases is 2.9%
Service delivery points:
• >5,940 DOTS centers
• >1,925 AFB centers
• 245 GeneXpert sites
• 8 TB culture labs
6. Introduction---2
Real time paperless data century –
the role of internet.
• “Chose technology that aligns with fiscal realities;
technology that are flexible & scalable”
• “Engage stakeholders in the entire processes”
• “Implementing connectivity is a journey and should be
Step wise”
• “Who is the costumer, & what is/are the goals of the
connectivity”
• “Management of expectations”
Lombardo, & Buckeridge (2007)
7. Lab connectivity in Nigeria
GeneXpert
Health
Systems
Connects the device via
secure network. Allows
automatic real-time
reporting of test results.
Routes the information so it
can become “actionable”
within the health system.
8. What are we connecting and
why?
GH Kumo
Kwali GH
IDH Kano
Zankli Lab
NIMR Yaba
SMS
Email
Computer
Other Systems:
e-TB Manager
DHIS2
GeneXpert
13. Results ---2
Real time feedback to patients and clinicians on
readiness of result
Real time notification/Alert to state program on
MTB/Rif resistance case
Early alert:
• Non functioning machine
• Cartridge stock level
• Warranty expiration
• Error rates
Timely reporting of appropriate indicators
14. Challenges:
Variation/Availability of internet by states/lab sites
Quality of primary data-incompleteness of variables in
request forms
Summary dashboard not available for the direct user
Lack of unique identification number with difficulties
to link GxAlert with other electronic reporting system
Legal framework or enabling policy on electronic
reporting
Security, privacy and confidentiality related issues
(currently non connection among military sites)
15. What are we asking for now
How can we…
• Sustain Connectivity
• Have Patient Unique Identifier
• Integrate with other systems (e-TB, DHIS)
• Dedicated Staff to Train, Provide on Site
Supportive Supervision, Monitor and
Troubleshoot when a lab does not report
• Connect system with other diagnostic tools